<DOC>
	<DOC>NCT02061826</DOC>
	<brief_summary>The purpose of the study is to establish drug-induced liver injury databases in China, make criteria for Chinese drug-induced liver injury patients and evaluate the application of certain circulating miRNA in diagnosis or treatment of drug-induced liver injury.</brief_summary>
	<brief_title>Establishment of Drug-induced Liver Injury Databases and Application of Circulating microRNA(miRNA)</brief_title>
	<detailed_description>Firstly, this study collects some retrospective data. Analyse these data and establish certain unique diagnostic criteria for Chinese. Then collect prospective data and validate the criteria. Otherwise,collect blood sample or other sample of the patients and study certain miRNA in diagnosis or treatment of drug-induced liver injury.</detailed_description>
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Drug-Induced Liver Injury</mesh_term>
	<criteria>Males and females between the age of 18 to 70 years Women in childbearing period taking some contraception measures Patients with onset of acute liver injury attributed to antituberculosis drugs or antineoplastic drugs, Roussel Uclaf Causality Assessment Method（RUCAM ） score≥6 Written informed consent can be obtained, some patients agree with liver biopsy Viral hepatitis Alcoholic liver disease or nonalcoholic liver disease Wilson's disease or other inherited metabolic liver diseases Autoimmune liver diseases Any dysfunction of liver Malnutrition Chronic diseases such as HIV,severe heart diseases, severe brain diseases or chronic kidney diseases Patients who can not complete followups on time</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>